Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database.

× No keyword cloud information.

5 in total

Review 1. Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases.

Authors: Ariela Holmer; Siddharth Singh
Journal: Expert Rev Clin Immunol Date: 2019-07-25 Impact factor: 4.473

2. Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis.

Authors: Thomas Ochsenkühn; Cornelia Tillack; Daniel Szokodi; Shorena Janelidze; Fabian Schnitzler
Journal: United European Gastroenterol J Date: 2019-12-12 Impact factor: 4.623

Review 3. Inhibition of interleukin-12 and/or interleukin-23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?

Authors: Elizabeth N Ergen; Nabiha Yusuf
Journal: Exp Dermatol Date: 2018-07 Impact factor: 3.960

Review 4. Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis.

Authors: Nicolás Lundahl Ciano-Petersen; Sergio Muñiz-Castrillo; Cristina Birzu; Alberto Vogrig; Antonio Farina; Macarena Villagrán-García; Bastien Joubert; Dimitri Psimaras; Jérôme Honnorat
Journal: Brain Commun Date: 2022-08-20

5. A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.

Authors: Emmanouil Charakopoulos; Ioannis Spyrou; Nora-Athina Viniou; Nefeli Giannakopoulou; Sevastianos Hatzidavid; Panagiotis Theodorou Diamantopoulos
Journal: Medicine (Baltimore) Date: 2020-05-22 Impact factor: 1.817

5 in total